Drawing for K TREATMENTS

USPTO serial 79400910

K TREATMENTS

Reviewed by CopyMark Law Group

Reg. 7617332Status 700Registered
Filing date
Status date
Registration date
Dec 24, 2024
Examiner
BROWN, BARBARA TROFFKIN
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with K TREATMENTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel M. Gurfinkel

Daniel M. Gurfinkel Dennemeyer & Associates, LLC.230 West Monroe Street, Suite 2100Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
005Adjuvants for medical purposes; Medicinal healthcare preparations, namely, for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders; Sanitary preparations for medical use; Food supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Nutritional supplements; Vitamin supplements; Protein supplements; Diagnostic preparations for medical or veterinary purposes; Pharmaceuticals for the treatment of erectile dysfunction; Vitamins and vitamin preparations; quantum-medical preparations and bio-cybernetic pharmaceutical preparations for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders and for hormonal system regulation; Medical preparations for slimming purposes; Nasal spray preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Anti-inflammatory preparations; Pharmaceutical preparations for suppressing tumors; tumor suppressing agents; Pharmaceutical preparations for the treatment of viral diseases; Vaginal moisturizers; Vaginal lubricants; Vaginal antifungals; Vaginal washes for medical purposes; Vaginal suppositories for the prevention and treatment of infectionsACTIVE—
042Research in the field of quantum physics and quantum chemistry; Research in the field of quantum communication technology; Research and development in the medical and biotechnology fields; Research and development in the medical field for pain treatment; Consulting services in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research in the field of bio-cybernetic regulators; custom design of quantum electromagnetic transformers; custom design of quantum electromagnetic inductors; custom design of quantum electromagnetic transformers and electromagnetic inductors for pain treatment; Technical consultancy in relation to technical research in the field of food and beverages; Cosmetic research; Scientific research relating to cosmetics; resarch laboratory analysis in the field of cosmetics; Testing of cosmeticsACTIVE—
044Performing bio-cybernetic diagnosis of diseases; Health care services, namely, bio-cybernetics therapy; medical services; Performing diagnosis of diseases using quantum-mechanics; medical treatment using quantum-chemical and quantum-physical technology; Regenerative medicine services; Alternative medicine services; Health assessment services; Providing nutritional information about food; Consulting services in the fields of health and nutritionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 24, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 24, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 5, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 18, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 18, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 25, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 24, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 24, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 5, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 5, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 16, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 27, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Sep 27, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 27, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 27, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 9, 2024RFNTREFUSAL PROCESSED BY IB—
Aug 20, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 20, 2024RFRRREFUSAL PROCESSED BY MPU—
Aug 10, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 9, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 8, 2024DOCKASSIGNED TO EXAMINER—
Aug 7, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 7, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 7, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 25, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance